Our gene expression results corroborate these findings, showing that Bmi-1 was overexpressed in all tumor grades evaluated; this expression was 1.15-fold higher in GBM compared with that in grade II astrocytomas. The gene discussed is BMI1; the disease is astrocytoma (excluding glioblastoma).